EPIZYME INC's ticker is EPZM and the CUSIP is 29428V104. A total of 1 filers reported holding EPIZYME INC in Q3 2022. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2022 | $22,000 | +29.4% | 15,000 | 0.0% | 0.00% | +100.0% |
| Q1 2022 | $17,000 | -55.3% | 15,000 | 0.0% | 0.00% | -66.7% |
| Q4 2021 | $38,000 | -65.1% | 15,000 | -29.2% | 0.00% | -66.7% |
| Q3 2021 | $109,000 | -35.1% | 21,200 | +5.0% | 0.01% | -30.8% |
| Q2 2021 | $168,000 | -4.5% | 20,200 | 0.0% | 0.01% | -23.5% |
| Q1 2021 | $176,000 | -88.4% | 20,200 | -85.6% | 0.02% | -89.2% |
| Q4 2020 | $1,518,000 | +7.4% | 139,800 | +18.1% | 0.16% | -5.4% |
| Q3 2020 | $1,413,000 | -10.8% | 118,400 | +20.1% | 0.17% | -19.3% |
| Q2 2020 | $1,584,000 | +77.6% | 98,600 | +71.5% | 0.21% | +56.8% |
| Q1 2020 | $892,000 | +68.0% | 57,500 | +166.2% | 0.13% | +140.0% |
| Q4 2019 | $531,000 | – | 21,600 | – | 0.06% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| RP Management, LLC | 31,833,334 | $47,750,000 | 19.42% |
| MPM BioImpact LLC | 3,425,202 | $3,939,000 | 1.06% |
| Palo Alto Investors LP | 6,774,541 | $7,791,000 | 0.60% |
| Foresite Capital Management I, LLC | 143,759 | $165,000 | 0.29% |
| PLATINUM INVESTMENT MANAGEMENT LTD | 6,603,870 | $7,594,000 | 0.23% |
| Rock Springs Capital Management LP | 7,267,696 | $8,358,000 | 0.21% |
| BP PLC | 24,687 | $28,000 | 0.16% |
| NewGen Asset Management Ltd | 250,000 | $288,000 | 0.13% |
| GSA CAPITAL PARTNERS LLP | 467,836 | $538,000 | 0.07% |
| Frazier Life Sciences Management, L.P. | 739,369 | $850,000 | 0.07% |